I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
0.8267
-0.0256 (-3.00%)
Apr 25, 2025, 10:40 AM EDT - Market open
I-Mab Market Cap
I-Mab has a market cap or net worth of $67.38 million as of April 25, 2025. Its market cap has decreased by -53.62% in one year.
Market Cap
67.38M
Enterprise Value
-100.05M
1-Year Change
-53.62%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has decreased from $138.05M to $67.38M, a decrease of -51.19%. That is a compound annual growth rate of -12.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 69.46M | 0.35% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.57B |
| UnitedHealth Group | 389.10B |
| Johnson & Johnson | 380.32B |
| AbbVie | 307.75B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.77B |
| AstraZeneca | 210.34B |
| Novartis AG | 209.93B |